LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all patients with CLL require therapy. Inspite of all the latest advances, the iwCLL continue to endorses watchful observation for clients with asymptomatic condition.86 This recommendation relies on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)